714.8500 -10.55 (-1.45%)
NSE Oct 01, 2026 15:31 PM
Volume: 244.8K
 

714.85
-1.45%
Axis Direct
We have initiating coverage on SOLARA with BUY rating and a target price of Rs 1,350 (P/E of 18x for FY23E earnings) which implies an upside of 25% from the current levels.
Solara Active Pharma has gained 24.17% in the last 3 Months
More from Solara Active Pharma Sciences Ltd.
Recommended